乳腺浸润性癌病理报告国际数据集:ICCR推荐
国际癌症报告合作组织(ICCR)发布首个乳腺浸润性癌切除标本病理报告国际数据集。由乳腺病理学家、外科医生和肿瘤学家组成的国际专家小组基于证据综述制定核心与非核心数据项,经国际公开咨询后定稿。该数据集旨在促进高质量标准化病理报告,改善多学科沟通和数据可比性。
要点
- ICCR发布首个乳腺浸润性癌病理报告国际数据集,含核心与非核心数据项。
- 数据集附结构化报告指南,已在ICCR网站发布。
- 采用该数据集可提高报告一致性、促进多学科沟通和数据可比性。
核心结论
- 该首个乳腺浸润性癌国际数据集旨在促进高质量、标准化的病理报告。
- 广泛采用将提高报告一致性、促进多学科沟通并增强数据可比性,从而改善患者管理。
研究设计与样本
- 遵循ICCR既定数据集开发流程。
- 国际专家小组由乳腺病理学家、一名外科医生和一名肿瘤学家组成。
- 基于对当前证据的批判性回顾和讨论准备核心与非核心数据项草案。
- 经国际公开咨询后定稿并批准,数据集包含结构化报告指南并在ICCR网站发布。
主要发现
- 当前国家或地区乳腺浸润性癌病理报告指南在某些方面存在差异,导致报告实践不同和数据缺乏可比性。
- 每个数据项附有评论,解释选择为核心或非核心元素的理由、临床相关性,并标出潜在分歧或证据缺乏领域,此时形成共识立场。
临床怎么用
- 采用该数据集进行乳腺浸润性癌切除标本的病理报告,以促进标准化和一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Current national or regional guidelines for the pathology reporting on invasive breast cancer differ in certain aspects, resulting in divergent reporting practice and a lack of comparability of data. Here we report on a new international dataset for the pathology reporting of resection specimens with invasive cancer of the breast. The dataset was produced under the auspices of the International Collaboration on Cancer Reporting (ICCR), a global alliance of major (inter-)national pathology and cancer organizations. METHODS AND RESULTS: The established ICCR process for dataset development was followed. An international expert panel consisting of breast pathologists, a surgeon, and an oncologist prepared a draft set of core and noncore data items based on a critical review and discussion of current evidence. Commentary was provided for each data item to explain the rationale for selecting it as a core or noncore element, its clinical relevance, and to highlight potential areas of disagreement or lack of evidence, in which case a consensus position was formulated. Following international public consultation, the document was finalized and ratified, and the dataset, which includes a synoptic reporting guide, was published on the ICCR website. CONCLUSIONS: This first international dataset for invasive cancer of the breast is intended to promote high-quality, standardized pathology reporting. Its widespread adoption will improve consistency of reporting, facilitate multidisciplinary communication, and enhance comparability of data, all of which will help to improve the management of invasive breast cancer patients.
引用
- Ellis I, Webster F, Allison KH, et al. Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2024. PMID: 38719547. doi:10.1111/his.15191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。